Network of Cord Blood Bank in Asia High Quality Cord Blood For Asian patients.....
It is with great grief for us that Dr. Shigetaka Asano, President of AsiaCORD, and Professor Emeritus of University of Tokyo, Japan, passed away on August 12, 2020, age 77 years.
On behalf of AsiaCORD, we would like to express our condolences. He was one of the founding members of AsiaCORD established in 2000. He devoted a great energy to get together great scientists in Asia and communicate with them. He always cherished friendship, especially in Asia.
His history In 1968, he graduated from the Faculty of Medicine, The University of Tokyo.
In 1980, he started lifelong projects on granulocyte colony-stimulating factor (G-CSF) and hematopoietic transplantation.
In 1990-2004, he devoted his energy to development of The Institute of Medical Science, The University of Tokyo in the field of translational studies including CBT and CB banking.
In 2019, the last lunch in Tokyo at Japanese Society ofHematology annual meeting.
AsiaCORD
Tributes to Professor Shigetaka Asano
To family and colleagues of Professor Shigetaka Asano
A Letter of Condolence
Dear friends,
I am very sorry to hear the sad news that Prof. Shigetaka Asano passed away. Please accept my sincere and heartfelt condolences. The last time I met him in a The 81th Annual meeting of JSH in Tokyo Japan last year, and wanted to invite him to give speech for our China Cord Blood Symposium and AsiaCORD meeting Nov this year. His passing will be a huge loss for us and the field of medicine.
Prof. Shigetaka Asano is a wonderful man of great learning, and contributes his whole life in Hematology fighting the blood diseases and bringing new life to numerous patients. As the founder and former president of AsiaCORD, he successfully led this organization and brought the prosperous development of Cord Blood transplantation and its scientific research in Asia, and especially drove Japan become world’s leading country in cord blood treatment and its related technology.
As a friends and inferiors, we will follow his spirit of tireless pursuit of science and his management philosophy, and continue to bring the development of hematology and cord blood to a new height.
Please accept my deepest sympathies. We will always miss him.
Kaiyan LIU
Professor of internal medicine
Vice Chairman of Peking University Institute of Hematology
Chairman of AsiaCORD
